NPs Basic Information
|
Name |
(R,3E,5E)-1-(3,5-dihydroxy-2,4-dimethylphenyl)-1-methoxyhepta-3,5-dien-2-one
|
| Molecular Formula | C16H20O4 | |
| IUPAC Name* |
1-(3,5-dihydroxy-2,4-dimethylphenyl)-1-methoxyhepta-3,5-dien-2-one
|
|
| SMILES |
CC=CC=CC(=O)C(OC)c1cc(O)c(C)c(O)c1C
|
|
| InChI |
InChI=1S/C16H20O4/c1-5-6-7-8-13(17)16(20-4)12-9-14(18)11(3)15(19)10(12)2/h5-9,16,18-19H,1-4H3/b6-5+,8-7+/t16-/m1/s1
|
|
| InChIKey |
ACLGASWHSGTLJE-KBHRAGRXSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was calculated by STOUT. Reference: PMID:33906675.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 276.33 | ALogp: | 3.1 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 66.8 | Aromatic Rings: | 1 |
| Heavy Atoms: | 20 | QED Weighted: | 0.632 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -4.726 | MDCK Permeability: | 0.00001970 |
| Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.137 |
| Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.005 |
| 30% Bioavailability (F30%): | 0.01 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.152 | Plasma Protein Binding (PPB): | 96.16% |
| Volume Distribution (VD): | 0.485 | Fu: | 2.96% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.11 | CYP1A2-substrate: | 0.545 |
| CYP2C19-inhibitor: | 0.036 | CYP2C19-substrate: | 0.712 |
| CYP2C9-inhibitor: | 0.039 | CYP2C9-substrate: | 0.701 |
| CYP2D6-inhibitor: | 0.038 | CYP2D6-substrate: | 0.64 |
| CYP3A4-inhibitor: | 0.041 | CYP3A4-substrate: | 0.469 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 4.994 | Half-life (T1/2): | 0.659 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.02 | Human Hepatotoxicity (H-HT): | 0.339 |
| Drug-inuced Liver Injury (DILI): | 0.08 | AMES Toxicity: | 0.226 |
| Rat Oral Acute Toxicity: | 0.668 | Maximum Recommended Daily Dose: | 0.948 |
| Skin Sensitization: | 0.955 | Carcinogencity: | 0.106 |
| Eye Corrosion: | 0.012 | Eye Irritation: | 0.907 |
| Respiratory Toxicity: | 0.949 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005051 |  |
0.746 | D05QDC |  |
0.300 | ||
| ENC001748 |  |
0.508 | D0B1IP |  |
0.268 | ||
| ENC002528 |  |
0.485 | D0L5FY |  |
0.233 | ||
| ENC005230 |  |
0.397 | D0U0OT |  |
0.224 | ||
| ENC002336 |  |
0.397 | D0V9EN |  |
0.222 | ||
| ENC004879 |  |
0.394 | D06GIP |  |
0.206 | ||
| ENC004624 |  |
0.382 | D0Y7PG |  |
0.202 | ||
| ENC005368 |  |
0.378 | D0U5CE |  |
0.200 | ||
| ENC004049 |  |
0.375 | D03LGG |  |
0.200 | ||
| ENC002196 |  |
0.370 | D0JO3U |  |
0.200 | ||